Skip to main navigation Skip to search Skip to main content

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

  • Sarah Jenkins
  • , Wei Zhang
  • , Seth M. Steinberg
  • , Darryl Nousome
  • , Nicole Houston
  • , Xiaolin Wu
  • , Terri S. Armstrong
  • , Eric Burton
  • , Dee Dee Smart
  • , Ritu Shah
  • , Cody J. Peer
  • , Brett Mozarsky
  • , Oluwatobi Arisa
  • , William D. Figg
  • , Tito R. Mendoza
  • , Elizabeth Vera
  • , Priscilla Brastianos
  • , Scott Carter
  • , Mark R. Gilbert
  • , Carey K. Anders
    • Roisín M. Connolly, Carol Tweed, Karen L. Smith, Imran Khan, Stanley Lipkowitz, Patricia S. Steeg, Alexandra S. Zimmer
  • National Institutes of Health
  • Leidos Inc
  • Massachusetts General Hospital
  • Harvard University
  • Duke University
  • Johns Hopkins University
  • University of Maryland, Baltimore

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science